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k University of Medicine and Pharmacy, “Carol Davila”, Bucharest, RomaniaWe thank Lonardo et al. (2016) for their comments on our meta- may be associatedwith a low risk for one disease outcome butwith high
analysis on the relationship between alcohol consumption and hepatic
steatosis (Roerecke et al., 2016). We would like to clarify our position
on overall risk associated with alcohol consumption and speciﬁcally
on the risk of hepatic steatosis. First, as we have stated in our paper,
we are in agreement with Lonardo et al. that a distinction between
alcoholic and non-alcoholic hepatic steatosis has little meaning because
alcohol is only one of the risk factors for liver disease, including non-
alcoholic fatty liver disease. Different dimensions of alcohol consump-
tion should be distinguished in this regard as non-regular binge drink-
ing among moderate drinkers seems to increase the risk for hepatic
steatosis. However, other risk factors also play a role, and the interac-
tions among all risk factors determine the overall risk for liver injury.
The large heterogeneity we observed in countries other than Japan
underlines that risk factors other than alcohol play a substantial role
in risk for hepatic steatosis and precludes us from clearly identifying
the role alcohol plays in the development of hepatic steatosis. Thus,
categorizing the etiology of liver injury based on one risk factor does
not make much sense.
Second, when talking about risk associated with alcohol consump-
tion, it makes little sense to use words such as safe. Rather, risk needs
to be examined for each disease outcome separately because pathways
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matter how little alcohol is consumed (Shield et al., 2016), and no
level of alcohol consumption is safe in this case. Consequently,
guidelines for alcohol consumption are considered ‘low-risk’ drinking
guidelines (Stockwell & Room, 2012), i.e. no level of alcohol consump-
tion is safe.
Third, the term paradox gives evidence that we do not yet fully un-
derstand the etiology of liver disease and the role alcohol plays in it.
Any comprehensive theory of alcohol's effect on hepatic steatosis or
other forms of liver disease should be able to explain the difference in
associations our meta-analysis has shown.References
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